Back to libraryMetabolic

SLU-PP-332

Research profile · How we handle evidence

Estrogen-related receptor alpha (ERRα) agonist that enhances oxidative metabolism and exercise endurance.

Evidence Score

40/100

Preclinical signal

Category

Metabolic

Therapeutic area

Standard Dose

10-30mg

Daily

Half-life

~8 hr

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

SLU-PP-332 is discussed as an ERRα (estrogen-related receptor alpha) agonist. In preclinical research, ERRα activation is tied to shifts toward oxidative metabolism, changes in mitochondrial function, and improved exercise-related performance measures. The exact effect size and translation to humans are not established, so it’s still best treated as an investigational research compound.

Mechanism of Action

SLU-PP-332 is discussed as an ERRα (estrogen-related receptor alpha) agonist. In preclinical research, ERRα activation is tied to shifts toward oxidative metabolism, changes in mitochondrial function, and improved exercise-related performance measures. The exact effect size and translation to humans are not established, so it’s still best treated as an investigational research compound.

MetabolicFat LossAthletic

Benefits

  • Enhanced metabolism
  • Improved endurance
  • Fat oxidation
  • Exercise mimetic effects

Side Effects

  • Generally well-tolerated

Contraindications

No entries listed.

Structure & Sequence

View 3D structure

Verified structure

SLU-PP-332

Sequence illustration backed by PubChem match.

Verified via PubChemMatched by casNumber
C18H14N2O2290.3 DaCAS 303760-60-32 residues
Source: PubChemLookup: 303760-60-3InChIKey RNZIMBFHRXYRLL-XDHOZWIPSA-N
Amino Acid Sequence
N/A (small molecule ERRα agonist; not a peptide)
Molecular Weight
290.3 Da
Chemical Formula
C18H14N2O2
CAS Number
303760-60-3
InChIKey
RNZIMBFHRXYRLL-XDHOZWIPSA-N

Stack & Route Context

Stacks with

  • AICAR
  • MOTS-c

Administration

Subcutaneous

Research Status

Research compound for metabolic enhancement

Approval Status

Preclinical

Sports Legal

Permitted

References

  1. 1

    SLU-PP-332 — overview and ERRα agonist properties

    2024

    View source
  2. 2

    SLU-PP-332 (ERRα agonist) — product/technical summary

    2024

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.